This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Due diligence call on Ion by Intuitive Surgical, A robotic-assisted endoluminal platform for minimally invasive peripheral lung biopsy

Ticker(s): ISRG

Who's the expert?

A Pulmonologist with knowledge and experience in performing lung biopsies

Interview Questions
Q1.

Please tell us about your clinical experience. How many bronchoscopic biopsies do you undertake on a yearly basis? What percent of them have inconclusive results? What is the most common reason for this? 

Added By: slingshot_insights
Q2.

How hard is it to perform the biopsy procedure when it involves finding nodules in the peripheral lung?

Added By: slingshot_insights
Q3.

What % of total biopsies have to be done far into the peripheral lung? What % of cases require finding nodules outside airways? And how hard are those procedures to perform without a robotic assisted device?

Added By: slingshot_insights
Q4.

How does Ion compare to manual techniques or ENB technology, in regards to 180 degrees articulation in any direction, airway generation access, and tip deflection correction?

Added By: slingshot_insights
Q5.

How important is the ability to repeatedly biopsy the same target, real time confirmation of a representative tissue sample and changing the sample location in the same area, that the Ion device provides?

Added By: slingshot_insights
Q6.

Have you seen an increased rate of adoption of robotic assisted biopsies performed by clinicians recently?

Added By: slingshot_insights
Q7.

How has COVID-19 influenced the detection procedures in mild to serious cases? Has there been a change in the number of biopsies performed?

Added By: slingshot_insights

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.